CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | eJHaem |
Online Access: | https://doi.org/10.1002/jha2.63 |